Specialty Chemicals firm Camlin Fine Sciences announced Q1FY23 Result :
Q1FY23 Revenues constant despite shutdown of Diphenol Plant at Dahej for 4 weeks.
Robust growth in Blends business continues
Increase in Operational EBITDA despite higher energy cost in CFS Europe continuing in current quarter
Energy cost in subsidiary CFS Europe SpA, Italy remained at high level due to Russia-Ukraine conflict. For Q1 FY 23, the said costs were higher by Rs. 47.8 mn as compared to Q4 FY22 and Rs. 255.8 mn as compared to Q1 FY22.
The impact has been recovered to some extent by increase in selling prices during Q1 FY23 and Q4 FY22.
Capital expansion plan of Methyl / Ethyl Vanillin is in final stage, commercial production expected in near future
Debottlenecking of Diphenol Plant completed in May'22, capacity enhanced to 15,000 MT from 10,000 MT
CAMLIN FINE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2022 ,inter alia, to consider and approve Intimation about the Board Meeting of Camlin Fine Sciences Limited (the 'Company') to be held on August 12, 2022